JLE

European Journal of Dermatology

MENU

Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria Volume 30, numéro 6, November-December 2020

Citer cet article

Citation de l'article, à la forme « Vancouver » :

Zoe Apalla, Theodoros Sidiropoulos, Evaggelia Kampouropoulou, Marina Papageorgiou, Aimilios Lallas, Elizabeth Lazaridou, Maria Smaragdi, Florentina Delli. Real-life, long-term data on efficacy, safety, response and discontinuation patterns of omalizumab in a Greek population with chronic spontaneous urticaria. European Journal of Dermatology. 2020;30(6):716-722. doi:10.1684/ejd.2020.3919

Télécharger (RIS) Ajouter dans ma bibliographie

Les citations dans ma bibliographie.